Mondelez International, Inc. (MDLZ) fair value analysis
S&P 500 & Nasdaq · Updated 2026-10-19
MDLZ price how computed
Forward Fair Value verdict
UndervaluedMDLZ is trading at a 10–25% discount to estimated fair value.
Based on TickrTrends' weekly Forward Fair Value model.
- Last price
- $60.41
- Sector
- Consumer Defensive
- 12-month range
- $51.51–$64.99
- Market cap
- $77.1B
- From 52-week high
- -7.0%
- Shares outstanding
- 1.28B
- Rank in Consumer Defensive by discount to fair value
- #31 of 61
Last price is our 2026-10-19 weekly price; the chart runs through 2026-10-16.
Mondelez International, Inc. is a multinational food and beverage company that manufactures and markets snacks, crackers, confectionery, and other packaged food products sold under brands including Oreo, Cadbury, Trident, and Halls. The company operates in numerous countries across North America, Europe, Latin America, Asia, the Middle East, and Africa.
MDLZ currently ranks #31 of 61 Consumer Defensive stocks by discount to fair value. It has screened as Undervalued for 6 consecutive weekly runs.
Fundamentals (4 quarters) how computed
- Market cap
- $77.1B
- P/E (trailing)
- 21x
- Revenue (TTM)
- $39.7B
- Net margin
- 8.9%
- EPS (TTM)
- $2.85
- Gross margin
- 42.6%
- Debt / equity
- 0.83
- Revenue growth (3-yr avg)
- 1.2%
- Shares outstanding
- 1.28B
Derived indicators how computed
- Quality grade
- D
- Margin trend
- Contracting
- 52-week position
- The upper-middle quarter of its range
- DCF cross-check
- Overvalued
Technicals how computed
- RSI (14-day)
- 63 · neutral
- 50-day average
- $61.69
- 200-day average
- $59.93
- Moving-average state
- 50-day above 200-day (golden cross state); price between the averages
Dividends how computed
- Paid, last 12 months
- $2.02 per share (4 payments)
- Yield on last price
- 3.34%
- Consecutive years of increases
- 12
- Last ex-dividend date
- 2026-09-30
- Last payment date
- 2026-10-14
Earnings how computed
- Next earnings report
- 2026-10-29 (post-market)
- Last 8 quarters vs consensus
- 7 beat, 0 missed
- Quarter by quarter
- 2026-06 ▲ beat (+9.0%)
2026-03 ▲ beat (+9.8%)
2025-12 ▲ beat (+2.9%)
2025-09 ▲ beat (+2.8%)
2025-06 ▲ beat (+7.4%)
2025-03 ▲ beat (+12.1%)
2024-12 ▬ met (0.0%)
2024-09 ▲ beat (+16.5%)
Analyst consensus how computed
This is not TickrTrends' verdict.
- Analyst ratings
- 15 buy · 8 hold · 0 sell (23 analysts)
- Consensus lean
- Buy-leaning
- Consensus price target
- $69
- Target vs last price
- +14.2%
What our data shows for MDLZ
- Our model validated 17 trailing price-to-earnings windows for MDLZ, built from quarterly earnings records.
- Shares are trading in the middle of their 12-month price range of $51.51–$64.99.
- The 14-day relative strength index sits at a neutral 63.
The exact numbers are one step away
- The precise Forward Fair Value dollar figure for MDLZ
- Exact discount / premium to today's price
- The normalized historical P/E behind the estimate, and how many quarters support it
- Forward EPS input and fiscal-year basis
- Screeners and rankings across the full S&P 500 and Nasdaq universes
Forward Fair Value applies a conservatively normalized historical price-to-earnings multiple to the consensus earnings estimate for the next full fiscal year; how TickrTrends computes it.
Recent MDLZ news
TickrTrends' derived news-sentiment signal for MDLZ is currently leaning positive, computed from recent coverage.
- What Capital Group Dividend Value (CGDV) Bought: Comcast Leads on Oct. 19 (gurufocus.com, 2026-10-21)
TickrTrends take: Mondelez International operates in the Consumer Defensive sector, where dividend-focused investment strategies may seek exposure to stable cash flow generators. The TickrTrends valuation assessment indicates MDLZ is currently undervalued, which could be relevant context if dividend-oriented funds like Capital Group's are selectively adding to positions in defensive equities. Investors monitoring valuation metrics should observe whether dividend-focused buying activity aligns with or diverges from the undervaluation signal in coming periods. - Mondelez International (MDLZ) Launches Gluten-Free Ritz Crackers Amid Growing Snack Market Demand (gurufocus.com, 2026-10-19)
TickrTrends take: Mondelez International's expansion into the gluten-free snacking category addresses a segment of the consumer defensive sector with demonstrated growth potential. Given TickrTrends' undervalued assessment, investors focused on valuation metrics should monitor whether this product innovation translates into margin expansion or market share gains that could support the current pricing. The success of category diversification efforts will be relevant to tracking whether the company's valuation discount reflects genuine opportunity or execution risk in an increasingly segmented snacking market. - Mondelez International’s 3.4% Yield: How Safe is the Payout? (insidermonkey.com, 2026-10-15)
TickrTrends take: Mondelez International trades at an undervalued level according to TickrTrends, which suggests the company may offer attractive risk-reward characteristics for income-focused investors examining the sustainability of its payout. Given the Consumer Defensive sector's typical emphasis on stable cash generation, a valuation discount combined with the dividend yield provides a framework for assessing whether the company's earnings and free cash flow can support the distribution over time. Investors considering this position should monitor whether the undervaluation persists and track the company's ability to maintain its payout while generating growth in a competitive snacking market.
More MDLZ news
- Is Mondelez’s Snack Empire Building a Wider Moat? (insidermonkey.com, 2026-10-03)
- MDLZ Looks 18.6% Undervalued on GF Value™ (gurufocus.com, 2026-09-24)
- Mondelez International Stock: Tasty Fundamentals, But Not A Tasty Price (NASDAQ:MDLZ) (seekingalpha.com, 2026-09-24)
What people are saying
Follow the MDLZ conversation: Stocktwits · Reddit · X
TickrTrends weekly updates
- 2026-10-19 — No material change this week: the verdict, bands and grades all held steady.
- 2026-10-12 — No material change this week: the verdict, bands and grades all held steady.
- 2026-10-11 — No material change this week: the verdict, bands and grades all held steady.
- 2026-10-10 — No material change this week: the verdict, bands and grades all held steady.
- 2026-10-06 — No material change this week: the verdict, bands and grades all held steady.
- 2026-09-28 — MDLZ moved into mixed trend territory this week as its 50/200-day trend state shifted from uptrend, while the Relative Strength Index zone improved from oversold to neutral conditions. The valuation verdict upgraded from Fairly valued to Undervalued, suggesting potential value at current price levels for this Consumer Defensive sector stock.
- 2026-09-21 — MDLZ's relative strength index moved into oversold territory this week, shifting from a neutral zone. The stock in the Consumer Defensive sector maintains a fairly valued assessment based on current valuation metrics.
- 2026-09-17 — No material change this week: the verdict, bands and grades all held steady.
Frequently asked questions
Is MDLZ stock undervalued?
Based on TickrTrends' Forward Fair Value model (updated 2026-10-19), MDLZ is trading at a 10–25% discount to estimated fair value and screens as undervalued. The exact fair value and discount are available to subscribers.
What is MDLZ's TickrTrends verdict?
MDLZ's current verdict is Undervalued, refreshed with every weekly Forward Fair Value run.
How does MDLZ compare to other Consumer Defensive stocks?
MDLZ ranks #31 of 61 Consumer Defensive stocks in TickrTrends' coverage by discount to fair value.
Is MDLZ overbought or oversold?
MDLZ's 14-day RSI is in neutral territory - neither overbought nor oversold.
Does MDLZ pay a dividend?
Yes. MDLZ paid $2.02 per share over the last twelve months (4 payments), a 3.34% yield on TickrTrends' last price, and has raised the annual total for 12 consecutive years. The last ex-dividend date was 2026-09-30.
When does MDLZ report earnings next?
MDLZ's next earnings report is scheduled for 2026-10-29 (post-market), per the published earnings calendar.
Does MDLZ usually beat earnings estimates?
Over its last 8 reported quarters MDLZ beat the consensus estimate 7 times and missed 0 times, by TickrTrends' comparison of reported and estimated EPS.
What do analysts say about MDLZ?
Of 23 analysts covering MDLZ, 15 rate it a buy, 8 a hold and 0 a sell - buy-leaning, with a consensus price target of $69 (+14.2% versus TickrTrends' last price). This is the analyst consensus, not TickrTrends' Forward Fair Value verdict.
More in Consumer Defensive
Head-to-head comparisons
MDLZ vs CENTA · MDLZ vs CL · MDLZ vs DG · MDLZ vs JBSS · MDLZ vs KR